Alto Neuroscience (ANRO) is a biotech to watch, because it has a major catalyst that is approaching in the 2nd half of 2024. This would be with respect to its lead drug known as ALTO-100, which is ...

Please provide your email address to receive an email when new articles are posted on . Changes in the aryl hydrocarbon receptor (AhR) are associated with atopic dermatitis. The efficacy of tapinarof, ...

Scientists at the University of California, San Francisco (UCSF), have discovered how to target a class of molecular switches called GTPases that are involved in a myriad of diseases—from Parkinson’s ...

"The studies […] exemplify progress in the rational design of [germline-targeting] HIV-1 vaccines, and what is being learned will guide [germline-targeting] programs for inducing [broadly neutralizing ...

Researchers at City of Hope have identified a new molecular target for treating pancreatic cancer and reported on a series of preclinical studies and the first clinical evidence indicating the ...

Drug discovery has long relied on two key strategies: target-based and phenotypic screening. Recombinant technologies and genomics opened the door to modern target-based drug discovery (TBDD), ...